Klaeske, K.; Lehmann, S.; Palitzsch, R.; Büttner, P.; Barten, M.J.; Jawad, K.; Eifert, S.; Saeed, D.; Borger, M.A.; Dieterlen, M.-T.
Everolimus-Induced Immune Effects after Heart Transplantation: A Possible Tool for Clinicians to Monitor Patients at Risk for Transplant Rejection. Life 2021, 11, 1373.
https://doi.org/10.3390/life11121373
AMA Style
Klaeske K, Lehmann S, Palitzsch R, Büttner P, Barten MJ, Jawad K, Eifert S, Saeed D, Borger MA, Dieterlen M-T.
Everolimus-Induced Immune Effects after Heart Transplantation: A Possible Tool for Clinicians to Monitor Patients at Risk for Transplant Rejection. Life. 2021; 11(12):1373.
https://doi.org/10.3390/life11121373
Chicago/Turabian Style
Klaeske, Kristin, Sven Lehmann, Robert Palitzsch, Petra Büttner, Markus J. Barten, Khalil Jawad, Sandra Eifert, Diyar Saeed, Michael A. Borger, and Maja-Theresa Dieterlen.
2021. "Everolimus-Induced Immune Effects after Heart Transplantation: A Possible Tool for Clinicians to Monitor Patients at Risk for Transplant Rejection" Life 11, no. 12: 1373.
https://doi.org/10.3390/life11121373
APA Style
Klaeske, K., Lehmann, S., Palitzsch, R., Büttner, P., Barten, M. J., Jawad, K., Eifert, S., Saeed, D., Borger, M. A., & Dieterlen, M.-T.
(2021). Everolimus-Induced Immune Effects after Heart Transplantation: A Possible Tool for Clinicians to Monitor Patients at Risk for Transplant Rejection. Life, 11(12), 1373.
https://doi.org/10.3390/life11121373
